×
About 2,821 results

ALLMedicine™ Hirsutism Center

Research & Reviews  1,289 results

Delayed identification of adolescent adrenal cortical carcinoma initially diagnosed as ...
https://doi.org/10.1016/j.jpag.2021.03.004
Journal of Pediatric and Adolescent Gynecology; Ziqin L, Yurui W et. al.

Mar 29th, 2021 - Adrenocortical carcinoma (ACC) is a rare, isolated malignancy. Here, we report the case of a 13-year-old girl who presented with secondary amenorrhoea, hirsutism and hypertension. Her clinical manifestations were interpreted as polycystic ovary sy...

Galanin and glypican-4 levels depending on metabolic and cardiovascular risk factors in...
https://doi.org/10.20945/2359-3997000000340
Archives of Endocrinology and Metabolism; Altinkaya SO

Mar 19th, 2021 - Galanin is a neuropeptide which has effects not only on metabolic syndrome but also on reproduction. Glypican-4 is an adipokine associated with insulin sensitivity by interacting directly with the insulin receptor. This study evaluated serum conce...

Ovarian Leydig cell tumor and postmenopausal hirsutism with signs of virilisation.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7978078
BMJ Case Reports; Ferrinho C, Silva E et. al.

Mar 18th, 2021 - A 71-year-old woman was referred to the endocrinology clinic to investigate postmenopausal hirsutism with 10 years of evolution. She had history of regular menses and menopause with 50 years old. Physical examination showed a male pattern facies, ...

The Role of Genetics, Epigenetics and Lifestyle in Polycystic Ovary Syndrome Developmen...
https://doi.org/10.1007/s43032-021-00515-4 10.1210/jc.2003-032046 10.1016/j.fertnstert.2003.10.004 10.1016/j.diabres.2017.06.011 10.2174/1381612822666160720155855 10.1016/j.jsbmb.2018.04.008 10.1177/1179558119874042 10.1016/j.steroids.2013.04.006 10.1016/j.fertnstert.2005.01.085 10.23736/S0026-4784.19.04404-6 10.1093/humupd/7.1.3 10.1007/BF03347535 10.1016/j.fertnstert.2016.01.024 10.1016/j.fertnstert.2018.04.024 10.1016/S0015-0282(00)01662-9 10.1073/pnas.95.25.14956 10.1210/jc.2005-1494 10.2147/TACG.S200341 10.1093/hmg/6.3.397 10.1210/jc.2005-2222 10.1016/j.mce.2016.06.011 10.1073/pnas.1400574111 10.1210/jc.2018-02496 10.1530/JOE-19-0096 10.4239/wjd.v6.i7.936 10.1038/ncomms9464 10.1038/srep42000 10.1002/kjm2.12008 10.3389/fendo.2019.00023 10.1016/S0015-0282(00)01616-2 10.1210/jc.2015-3776 10.1080/19396368.2019.1595217 10.1016/j.ajog.2020.04.004 10.1136/jmedgenet-2011-100727 10.1016/j.ijbiomac.2019.10.235 10.1016/j.lfs.2019.116940 10.1016/j.ijbiomac.2019.10.235 10.1210/jc.2006-0227 10.1016/j.ejogrb.2011.03.026 10.1369/jhc.2010.956615 10.1186/1471-2350-11-12 10.1186/s12881-020-0961-1 10.1093/humrep/des424 10.1136/jmedgenet-2011-100427 10.3389/fendo.2020.00274 10.1371/journal.pone.0168870 10.4274/jcrpe.2784 10.1042/BSR20190292 10.3389/fendo.2018.00504 10.1210/jc.2018-00544 10.1038/s41598-017-03555-6 10.1111/aogs.13719 10.1530/REP-18-0449 10.1038/nrg3230 10.1186/s13148-019-0657-6 10.1016/j.gene.2019.04.082 10.1530/REP-16-0071 10.2337/db12-0963 10.1155/2015/943659 10.1210/en.2019-00013 10.1093/humupd/dmx013 10.1177/1179558119871467 10.1038/s41591-018-0035-5 10.1186/s13048-019-0583-4 10.1016/j.rbmo.2018.05.011 10.1210/jc.2005-2757 10.1159/000494899 10.1016/j.ejogrb.2012.10.015 10.1152/ajpendo.00421.2012 10.1530/EJE-14-0253 10.1530/REP-14-0499 10.1007/BF03350781 10.1016/j.fertnstert.2014.12.109 10.1210/jc.2009-1849 10.1038/sj.ijo.0801994 10.1136/bmj.j1 10.1186/s10020-018-0060-3 10.1016/j.tem.2019.01.005 10.1093/humrep/det383 10.1186/s12958-016-0205-6 10.1111/j.1365-2265.2008.03247.x 10.1007/BF03401321 10.1016/j.dsx.2017.03.030 10.2174/1381612822666160714094404 10.1016/j.cmet.2019.09.005 10.1016/j.resmic.2018.09.002 10.1210/jc.2017-02153 10.1210/jc.2017-02799 10.1210/jc.2010-1658 10.1080/09513590.2017.1405931 10.1093/humrep/dey256
Reproductive Sciences (Thousand Oaks, Calif.); Bruni V, Capozzi A et. al.

Mar 12th, 2021 - Polycystic ovary syndrome (PCOS) is an endocrine-metabolic disease affecting about 20-25% of women in reproductive age. Different mechanisms could contribute to the development of its typical clinical features (i.e. hirsutism, acne, oligo-amenorrh...

A large ovarian steroid cell tumor-not otherwise specified with a unique combination of...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7934245
BMC Women's Health; Ismail S, Hraib M et. al.

Mar 5th, 2021 - Ovarian steroid cell tumors represent a rare category of sex cord-stromal tumors that constitute less than 0.1% of all ovarian tumors. These neoplasms are classified into three main subtypes according to the cell of origin: Leidyg cell tumors, str...

see more →

Guidelines  15 results

Screening and Management of the Hyperandrogenic Adolescent
https://www.acog.org/Clinical-Guidance-and-Publications/Committee-Opinions/Committee-on-Adolescent-Health-Care/Screening-and-Management-of-the-Hyperandrogenic-Adolescent

Sep 23rd, 2019 - Although androgen excess can manifest in many ways, the most common and recognizable symptoms are hirsutism and acne. Reports of hirsutism and acne should be taken seriously because of their possible association with medical disorders, their subst...

Hirsutism in Women
https://www.aafp.org/afp/2019/0801/p168.html

Jul 31st, 2019 - Hirsutism is the excessive growth of terminal hair in a typical male pattern in a female. It is often a sign of excessive androgen levels. Although many conditions can lead to hirsutism, polycystic ovary syndrome and idiopathic hyperandrogenism ac...

Evaluation and Treatment of Hirsutism in Premenopausal Women: An Endocrine Society Clinical ...
https://academic.oup.com/jcem/article/103/4/1233/4924418
Kathryn A. Martin

Mar 31st, 2018 - We suggest testing for elevated androgen levels in all women with an abnormal hirsutism score. We suggest against testing for elevated androgen levels in eumenorrheic women with unwanted local hair growth (i.

Evaluation and Treatment of Hirsutism in Premenopausal Women: An Endocrine Society Clin...
https://doi.org/10.1210/jc.2018-00241
The Journal of Clinical Endocrinology and Metabolism; Martin KA, Anderson RR et. al.

Mar 9th, 2018 - To update the "Evaluation and Treatment of Hirsutism in Premenopausal Women: An Endocrine Society Clinical Practice Guideline," published by the Endocrine Society in 2008. The participants include an Endocrine Society-appointed task force of seven...

No. 350-Hirsutism: Evaluation and Treatment.
https://doi.org/10.1016/j.jogc.2017.05.022
Journal of Obstetrics and Gynaecology Canada : JOGC = Jou... Liu K, Motan T et. al.

Oct 30th, 2017 - To review the etiology, evaluation, and treatment of hirsutism. A thorough history and physical examination plus selected laboratory evaluations will confirm the diagnosis and direct treatment. Pharmacologic interventions can suppress ovarian or a...

see more →

Clinicaltrials.gov  1,383 results

Delayed identification of adolescent adrenal cortical carcinoma initially diagnosed as ...
https://doi.org/10.1016/j.jpag.2021.03.004
Journal of Pediatric and Adolescent Gynecology; Ziqin L, Yurui W et. al.

Mar 29th, 2021 - Adrenocortical carcinoma (ACC) is a rare, isolated malignancy. Here, we report the case of a 13-year-old girl who presented with secondary amenorrhoea, hirsutism and hypertension. Her clinical manifestations were interpreted as polycystic ovary sy...

Galanin and glypican-4 levels depending on metabolic and cardiovascular risk factors in...
https://doi.org/10.20945/2359-3997000000340
Archives of Endocrinology and Metabolism; Altinkaya SO

Mar 19th, 2021 - Galanin is a neuropeptide which has effects not only on metabolic syndrome but also on reproduction. Glypican-4 is an adipokine associated with insulin sensitivity by interacting directly with the insulin receptor. This study evaluated serum conce...

Ovarian Leydig cell tumor and postmenopausal hirsutism with signs of virilisation.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7978078
BMJ Case Reports; Ferrinho C, Silva E et. al.

Mar 18th, 2021 - A 71-year-old woman was referred to the endocrinology clinic to investigate postmenopausal hirsutism with 10 years of evolution. She had history of regular menses and menopause with 50 years old. Physical examination showed a male pattern facies, ...

The Role of Genetics, Epigenetics and Lifestyle in Polycystic Ovary Syndrome Developmen...
https://doi.org/10.1007/s43032-021-00515-4 10.1210/jc.2003-032046 10.1016/j.fertnstert.2003.10.004 10.1016/j.diabres.2017.06.011 10.2174/1381612822666160720155855 10.1016/j.jsbmb.2018.04.008 10.1177/1179558119874042 10.1016/j.steroids.2013.04.006 10.1016/j.fertnstert.2005.01.085 10.23736/S0026-4784.19.04404-6 10.1093/humupd/7.1.3 10.1007/BF03347535 10.1016/j.fertnstert.2016.01.024 10.1016/j.fertnstert.2018.04.024 10.1016/S0015-0282(00)01662-9 10.1073/pnas.95.25.14956 10.1210/jc.2005-1494 10.2147/TACG.S200341 10.1093/hmg/6.3.397 10.1210/jc.2005-2222 10.1016/j.mce.2016.06.011 10.1073/pnas.1400574111 10.1210/jc.2018-02496 10.1530/JOE-19-0096 10.4239/wjd.v6.i7.936 10.1038/ncomms9464 10.1038/srep42000 10.1002/kjm2.12008 10.3389/fendo.2019.00023 10.1016/S0015-0282(00)01616-2 10.1210/jc.2015-3776 10.1080/19396368.2019.1595217 10.1016/j.ajog.2020.04.004 10.1136/jmedgenet-2011-100727 10.1016/j.ijbiomac.2019.10.235 10.1016/j.lfs.2019.116940 10.1016/j.ijbiomac.2019.10.235 10.1210/jc.2006-0227 10.1016/j.ejogrb.2011.03.026 10.1369/jhc.2010.956615 10.1186/1471-2350-11-12 10.1186/s12881-020-0961-1 10.1093/humrep/des424 10.1136/jmedgenet-2011-100427 10.3389/fendo.2020.00274 10.1371/journal.pone.0168870 10.4274/jcrpe.2784 10.1042/BSR20190292 10.3389/fendo.2018.00504 10.1210/jc.2018-00544 10.1038/s41598-017-03555-6 10.1111/aogs.13719 10.1530/REP-18-0449 10.1038/nrg3230 10.1186/s13148-019-0657-6 10.1016/j.gene.2019.04.082 10.1530/REP-16-0071 10.2337/db12-0963 10.1155/2015/943659 10.1210/en.2019-00013 10.1093/humupd/dmx013 10.1177/1179558119871467 10.1038/s41591-018-0035-5 10.1186/s13048-019-0583-4 10.1016/j.rbmo.2018.05.011 10.1210/jc.2005-2757 10.1159/000494899 10.1016/j.ejogrb.2012.10.015 10.1152/ajpendo.00421.2012 10.1530/EJE-14-0253 10.1530/REP-14-0499 10.1007/BF03350781 10.1016/j.fertnstert.2014.12.109 10.1210/jc.2009-1849 10.1038/sj.ijo.0801994 10.1136/bmj.j1 10.1186/s10020-018-0060-3 10.1016/j.tem.2019.01.005 10.1093/humrep/det383 10.1186/s12958-016-0205-6 10.1111/j.1365-2265.2008.03247.x 10.1007/BF03401321 10.1016/j.dsx.2017.03.030 10.2174/1381612822666160714094404 10.1016/j.cmet.2019.09.005 10.1016/j.resmic.2018.09.002 10.1210/jc.2017-02153 10.1210/jc.2017-02799 10.1210/jc.2010-1658 10.1080/09513590.2017.1405931 10.1093/humrep/dey256
Reproductive Sciences (Thousand Oaks, Calif.); Bruni V, Capozzi A et. al.

Mar 12th, 2021 - Polycystic ovary syndrome (PCOS) is an endocrine-metabolic disease affecting about 20-25% of women in reproductive age. Different mechanisms could contribute to the development of its typical clinical features (i.e. hirsutism, acne, oligo-amenorrh...

A large ovarian steroid cell tumor-not otherwise specified with a unique combination of...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7934245
BMC Women's Health; Ismail S, Hraib M et. al.

Mar 5th, 2021 - Ovarian steroid cell tumors represent a rare category of sex cord-stromal tumors that constitute less than 0.1% of all ovarian tumors. These neoplasms are classified into three main subtypes according to the cell of origin: Leidyg cell tumors, str...

see more →

News  117 results

Increased Risk of Meningioma With Cyproterone Acetate Use
https://www.medscape.com/viewarticle/945218

Feb 2nd, 2021 - New details confirm an increased risk of developing intracranial meningiomas after prolonged use of the hormonal product cyproterone acetate. Cyproterone acetate is a synthetic progestogen and potent anti-androgen that has been used in the treatme...

Metformin Not Better Than Oral Contraceptive for Treating PCOS-Related Hirsutism
https://www.medscape.com/viewarticle/936850

Sep 7th, 2020 - NEW YORK (Reuters Health) - Metformin monotherapy might be less effective than oral contraceptive pills (OCPs) for treating hirsutism in women with polycystic ovary syndrome (PCOS), according to a new Cochrane review. In fact, "OCP alone or metfor...

GPs Need Better Education on All Symptoms of PCOS, Say Patients
https://www.medscape.com/viewarticle/927116

Mar 18th, 2020 - Women who have polycystic ovary syndrome (PCOS) often feel their general practitioners (GPs) trivialize the condition as only a fertility problem and do not discuss any of the other long-term health consequences, new results from a UK survey revea...

EU Restricts High-Dose Cyproterone Because of Meningioma Risk
https://www.medscape.com/viewarticle/925271

Feb 13th, 2020 - Cyproterone products with daily doses of 10 mg or more should be restricted because of a risk of developing meningioma, says the safety committee of the European Medicines Agency. Products containing cyproterone 10 mg daily or more should be used ...

Screening and Management of the Hyperandrogenic Adolescent
https://www.acog.org/Clinical-Guidance-and-Publications/Committee-Opinions/Committee-on-Adolescent-Health-Care/Screening-and-Management-of-the-Hyperandrogenic-Adolescent

Sep 23rd, 2019 - Although androgen excess can manifest in many ways, the most common and recognizable symptoms are hirsutism and acne. Reports of hirsutism and acne should be taken seriously because of their possible association with medical disorders, their subst...

see more →

Patient Education  17 results see all →